Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
Abstract The promise of precision and personalized medicine is rooted in accurate, highly sensitive, and specific disease biomarkers. This is particularly true for cancer-a disease characterized by marked tumor heterogeneity and diverse molecular signatures. Although thousands of biomarkers have bee...
Guardado en:
Autores principales: | Grannum R. Sant, Kevin B. Knopf, David M. Albala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/adb7c741220b4a5fbd1231712d4b9900 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Precision oncology- the future of personalized cancer medicine?
por: Ann M. Bode, et al.
Publicado: (2017) -
Artificial intelligence for the next generation of precision oncology
por: Pedro J. Ballester, et al.
Publicado: (2021) -
Circulating tumor cells: quintessential precision oncology presenting challenges for biology
por: Rebecca J. Morris
Publicado: (2017) -
Network-based machine learning and graph theory algorithms for precision oncology
por: Wei Zhang, et al.
Publicado: (2017) -
Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology
por: Ianthe A. E. M. van Belzen, et al.
Publicado: (2021)